Periodic Reporting for period 1 - MaGMa (Applying Metabolomics to Unveil follow-up treatment biomarkers and Identify Novel TherapeuticTargets in Glioblastoma)

Glioblastoma multiforme (GBM) is a malignant tumour originating from glial cells. It is the most common and devastating form of brain tumour, containing self-renewing, tumorigenic cancer stem cells (CSCs) that contribute to tumour initiation and therapeutic resistance. It...